Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Maidu Pharmaceutical Research is a specialized Contract Research Organization (CRO) providing high-end drug metabolism and pharmacokinetics (DMPK) and bioanalytical services. Based in Changzhou, China, the company supports both domestic and international pharmaceutical clients through all stages of drug development, from lead optimization to clinical trials. Their core capabilities include LC-MS/MS bioanalysis, metabolite identification, and immunogenicity testing for biologics. Maidu operates under GLP-compliant standards and is known for its technical expertise in handling complex molecules and challenging matrices. The company's facilities are equipped with advanced instrumentation to provide high-quality data for regulatory submissions to the NMPA, FDA, and EMA. By integrating discovery and clinical bioanalysis, Maidu helps streamline the drug development process for its partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Maidu Pharmaceutical Research.